MarketWatch: Biotechnology
Pages: 39
Publisher: Datamonitor
Date Published: July 2006
Format: PDF
Price: $200
Overview
Datamonitor’s Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Biotechnology industry.
Table of Contents
In this month’s MarketWatch…
This month’s highlights
Page 2 – Key Announcements
Page 2 – Biotechnology News Round-up
Research & Development News
Page 4 – Opinion
Page 7 – Headlines
Page 7 – Research Update
Page 8 – Results Update
Regulatory News
Page 11 – Opinion
Page 12 – Headlines
Page 12 – Applications Update
Page 13 – Decisions Update
Alliances & Licensing News
Page 15 – Opinion
Page 16 – Headlines
Page 16 – Alliances Update
Page 17 – Licensing Update
Company Strategy News
Page 20 – Opinion
Page 23 – Headlines
Page 23 – Mergers & Acquisitions Update
Page 24 – Industry News Update
Feature Analysis
Page 26 – EntreMed hoping for success with Panzem/Avastin combo…
Page 27 – Vertex: next-generation hepatitis drugs within reach…
Page 28 – Cell Therapeutics’ Xyotax holds much promise for few patients…
Company Spotlight
Page 31 – Amgen Inc
Index
Page 38 – Pharma companies
Page 38 – Biotech companies
Page 39 – Key drugs
